Buspiron Mylan 5 mg Tablett Svíþjóð - sænska - Läkemedelsverket (Medical Products Agency)

buspiron mylan 5 mg tablett

mylan ab - buspironhydroklorid - tablett - 5 mg - buspironhydroklorid 5 mg aktiv substans; laktosmonohydrat hjälpämne - buspiron

Buspiron Actavis 5 mg Tablett Svíþjóð - sænska - Läkemedelsverket (Medical Products Agency)

buspiron actavis 5 mg tablett

actavis group ptc ehf. - buspironhydroklorid - tablett - 5 mg - buspironhydroklorid 5 mg aktiv substans; laktosmonohydrat hjälpämne - buspiron

Tempora 10 mg Tuggtablett Svíþjóð - sænska - Läkemedelsverket (Medical Products Agency)

tempora 10 mg tuggtablett

laboratoires sogeval - spironolakton - tuggtablett - 10 mg - laktosmonohydrat hjälpämne; spironolakton 10 mg aktiv substans; natriumlaurilsulfat hjälpämne - spironolakton - hund

Tempora 100 mg Tuggtablett Svíþjóð - sænska - Läkemedelsverket (Medical Products Agency)

tempora 100 mg tuggtablett

laboratoires sogeval - spironolakton - tuggtablett - 100 mg - laktosmonohydrat hjälpämne; natriumlaurilsulfat hjälpämne; spironolakton 100 mg aktiv substans - spironolakton - hund

Regkirona Evrópusambandið - sænska - EMA (European Medicines Agency)

regkirona

celltrion healthcare hungary kft. - regdanvimab - covid-19 virus infection - immunförsvaret sera och immunglobuliner, - regdanvimab is indicated for the treatment of adults with coronavirus disease 2019 (covid-19) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.

Qaialdo Evrópusambandið - sænska - EMA (European Medicines Agency)

qaialdo

nova laboratories ireland limited - spironolakton - edema; heart failure; liver cirrhosis; ascites; nephrotic syndrome; hyperaldosteronism; essential hypertension - antihypertensives and diuretics in combination - in the management of refractory oedema associated with congestive cardiac failure; hepatic cirrhosis with ascites and oedema, malignant ascites, nephrotic syndrome, diagnosis and treatment of primary aldosteronism, essential hypertension. neonates, children and adolescents should only be treated under guidance of a paediatric specialist (see sections 5. 1 och 5.

Buspiron Ebb 5 mg Tablett Svíþjóð - sænska - Läkemedelsverket (Medical Products Agency)

buspiron ebb 5 mg tablett

ebb medical ab - buspironhydroklorid - tablett - 5 mg - buspironhydroklorid 5 mg aktiv substans; laktosmonohydrat hjälpämne

Buspiron Ebb 10 mg Tablett Svíþjóð - sænska - Läkemedelsverket (Medical Products Agency)

buspiron ebb 10 mg tablett

ebb medical ab - buspironhydroklorid - tablett - 10 mg - buspironhydroklorid 10 mg aktiv substans; laktosmonohydrat hjälpämne

Buspiron Scand Pharm 10 mg Tablett Svíþjóð - sænska - Läkemedelsverket (Medical Products Agency)

buspiron scand pharm 10 mg tablett

merck nm ab - buspironhydroklorid - tablett - 10 mg - buspironhydroklorid 10 mg aktiv substans; laktosmonohydrat hjälpämne - buspiron

Buspiron 2care4 10 mg Tablett Svíþjóð - sænska - Läkemedelsverket (Medical Products Agency)

buspiron 2care4 10 mg tablett

2care4 aps - buspironhydroklorid - tablett - 10 mg - laktosmonohydrat hjälpämne; buspironhydroklorid 10 mg aktiv substans - buspiron